TONGHUA DONGBAO PHARMACEUTICAL
Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.
TONGHUA DONGBAO PHARMACEUTICAL
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
1985-01-01
Status:
Active
Total Funding:
283 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Apache Mobile Non Scaleable Content Euro DigiCert SSL Pound Sterling Japanese Yen
Stock Details
Company's stock symbol is SSE:600867
Investors List
DCP Capital
DCP Capital investment in Post-IPO Equity - Tonghua Dongbao Pharmaceutical
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-04-14 | POCTech Corporation | Tonghua Dongbao Pharmaceutical investment in Series B - POCTech Corporation | 100 M CNY |
| 2015-12-28 | AMOYTOP BIOTECH | Tonghua Dongbao Pharmaceutical investment in Funding Round - AMOYTOP BIOTECH | 50 M CNY |